SNV analysis revealed a high mutation rate of SDC1 in pan-cancer, Skin Cutaneous Melanoma (SKCM), Ovarian serous cystadenocarcinoma (OV), Colon adenocarcinoma (COAD) and UCEC. This evidence concerns the gene SDC1 and colon adenocarcinoma.